XWELL (XWEL) to Post Earnings on Monday

XWELL (NASDAQ:XWEL) is expected to post its Q2 2026 results before the market opens on Monday, August 17th. Analysts expect XWELL to post earnings of ($1.00) per share and revenue of $2.3710 million for the quarter. Interested persons can check the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Thursday, August 20, 2026 at 5:00 PM ET.

XWELL (NASDAQ:XWEL) last released its quarterly earnings data on Wednesday, May 20th. The company reported ($1.51) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.00) by ($0.51). The company had revenue of $6.64 million for the quarter, compared to the consensus estimate of $2.37 million. XWELL had a negative return on equity of 2,318.99% and a negative net margin of 81.43%.

XWELL Price Performance

Shares of XWEL opened at $1.02 on Monday. XWELL has a one year low of $0.26 and a one year high of $2.20. The company has a market cap of $8.65 million, a PE ratio of -0.18 and a beta of 1.03. The stock has a 50-day moving average of $1.10 and a 200-day moving average of $1.06.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the company. Weiss Ratings lowered XWELL from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, May 13th. Wall Street Zen lowered XWELL from a “hold” rating to a “sell” rating in a research report on Sunday, May 17th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has an average rating of “Sell”.

About XWELL

XWELL, Inc provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.